Thiogenesis Therapeutics, Corp.
TTI.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -62.78% | -48.59% | -50.09% | 14.34% | 3.58% |
| Total Receivables | 2.30% | -43.63% | -5.42% | 62.39% | -2.25% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.41% | -15.78% | -46.27% | 258.82% | 400.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -61.55% | -48.11% | -49.52% | 15.55% | 4.28% |
|
|
|||||
| Total Current Assets | -61.55% | -48.11% | -49.52% | 15.55% | 4.28% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -61.55% | -48.11% | -49.52% | 15.55% | 4.28% |
|
|
|||||
| Total Accounts Payable | 382.61% | 166.92% | -69.35% | -66.91% | -14.69% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 382.61% | 171.63% | -70.11% | -66.91% | -14.69% |
|
|
|||||
| Total Current Liabilities | 382.61% | 171.63% | -70.11% | -66.91% | -14.69% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 382.61% | 171.63% | -70.11% | -66.91% | -14.69% |
|
|
|||||
| Common Stock & APIC | 3.92% | -2.44% | -1.33% | 24.83% | 21.39% |
| Retained Earnings | -41.25% | -24.79% | -17.71% | -43.68% | -49.04% |
| Treasury Stock & Other | 15.29% | -0.56% | -12.94% | 4,808.56% | 10,086.32% |
| Total Common Equity | -90.36% | -62.28% | -43.15% | 23.40% | 5.80% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -90.36% | -62.28% | -43.15% | 23.40% | 5.80% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -90.36% | -62.28% | -43.15% | 23.40% | 5.80% |
|
|
|||||